The Debridement To Treat The Traumatic Corneal Abrasion
A Prospective, Randomized, Double-blind, Controlled Clinical Study of Corneal Debridement to Treat the Traumatic Corneal Abrasion
1 other identifier
interventional
156
1 country
1
Brief Summary
Patients who signed informed consent to participate in the study will receive corneal epithelial deplasia. The patient was instructed to follow up closely in the following year, and the recurrence of the patient was collected through wechat follow-up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 5, 2022
CompletedFirst Posted
Study publicly available on registry
September 9, 2022
CompletedStudy Start
First participant enrolled
December 31, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2024
CompletedSeptember 9, 2022
September 1, 2022
8 months
August 5, 2022
September 6, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
wound recurrence
Wound recurrence during 12 months after treatment.
month 12 after treatment
Secondary Outcomes (3)
Incidence of wound infection
week 1, week 2, month 1, month 2, month 3, month 6, month 9, and month 12.
The grading of pain for eyes
week 1, week 2, month 1, month 2, month 3, month 6, month 9, and month 12.
Corneal scar
week 1, week 2, month 1, month 2, month 3, month 6, month 9, and month 12.
Study Arms (2)
debridement+traditional treatment
EXPERIMENTALThe experimental group receives debridement of the abrasion wound before receiving traditional treatment including evofloxacin eye drops + befushu QID \* for 14 days, four times a day, and the corneal contact lens was worn for 2 weeks.
traditional treatment
ACTIVE COMPARATORThe traditional group receives evofloxacin eye drops + befushu QID \* for 14 days, four times a day, and the corneal contact lens was worn for 2 weeks.
Interventions
Surgical debridement for traumatic corneal epithelial abrasions
Eligibility Criteria
You may qualify if:
- The affected eye is traumatic corneal epithelial abrasion, and the specific criteria are as follows: A: Damage caused by one of the three high risk causes of recurrent corneal epithelial exfoliation defined as fingernails, paper, or plant leaves; B: Monocular disease; C: Eye pain, tears, photophobia and foreign body sensation when injured; D: Local defect of corneal epithelium was found at the time of injury, and fluorescein sodium staining was positive; E: The time from injury to first diagnosis is less than 24 hours.
- Be between the ages of 18 and 60.
- Patients volunteered to participate in the study and signed the informed consent, showing good compliance.
You may not qualify if:
- Corneal epithelial defect complicated with infection.
- Patients with other ocular surface diseases (such as eyelid insufficiency, eyelid gland dysfunction, Sjogren's syndrome, bullae keratopathy, corneal dystrophy, drug induced corneal toxicity, etc.).
- Pre-existing corneal disease (corneal degenerative disease or viral keratitis, etc.) or history of corneal surgery;
- Long-term contact lens wearers.
- Pregnant or lactating women; Severe impairment of heart, liver and kidney function; One who is mentally abnormal; People with other inflammatory or autoimmune diseases. Corneal epithelial defect complicated with infection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Zhaohui Yuan
Guangzhou, Guangdong, 510000, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- The participants didn't know where they were grouped,and the experimenters did not know about the trial either.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 5, 2022
First Posted
September 9, 2022
Study Start
December 31, 2022
Primary Completion
September 1, 2023
Study Completion
January 1, 2024
Last Updated
September 9, 2022
Record last verified: 2022-09
Data Sharing
- IPD Sharing
- Will not share